60657-93-4

Basic information

• Product Name: Dihydromollugin
• Synonyms: Dihydromollugin;2,2-Dimethyl-6-hydroxy-3,4-dihydro-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester;3,4-Dihydro-6-hydroxy-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester;3,4-Dihydromollugin
• CAS NO: 60657-93-4
• Molecular Formula: C17H18O4
• Molecular Weight: 286.32
• Mol File: 60657-93-4.mol
• Article Data: 12

Chemical Properties

• Melting Point: 96-97 °C
• Boiling Point: 448.2±45.0 °C(Predicted)
• Appearance: /
• Density: 1.212±0.06 g/cm3(Predicted)
• PKA: 8.59±0.40(Predicted)
• CAS DataBase Reference: Dihydromollugin(CAS DataBase Reference)
• NIST Chemistry Reference: Dihydromollugin(60657-93-4)
• EPA Substance Registry System: Dihydromollugin(60657-93-4)

Safety Data

• Hazardous Substances Data: 60657-93-4(Hazardous Substances Data)

Usage

General Description

Dihydromollugin is a naturally occurring chemical compound that is found in the plant Mollugo pentaphylla. It is classified as a triterpenoid saponin and has been the subject of various scientific studies due to its potential therapeutic properties. Research has shown that dihydromollugin possesses anti-inflammatory, antioxidant, and anti-cancer properties. It has also been reported to have potential effects on cardiovascular health, including the ability to lower blood pressure and reduce cholesterol levels. Additionally, dihydromollugin has been studied for its potential as a treatment for osteoporosis, with preliminary findings suggesting that it may have a positive impact on bone health. Overall, the compound shows promise as a natural remedy for a range of health conditions and is a subject of ongoing research in the fields of medicine and pharmacology.

Upstream product

• 571-60-8 1,4-Dihydroxynaphthalene 
• 130-15-4 [1,4]naphthoquinone 
• 107-86-8 3,3-dimethyl acrylaldehyde 
• 77060-74-3 methyl 1,4-dihydroxy-2-naphthoate 
• 78-79-5 isoprene 
• 556-82-1 3-methyl-2-buten-1-ol 
• 115-18-4 2-methyl-3-buten-2-ol 
• 31519-22-9 1,4-dihydroxy-2-naphthoic acid 
• 763-32-6 2-methyl-1-buten-4-ol 
• 186581-53-3 diazomethane 
• 83697-82-9 6-hydroxy-2,2-dimethyl-3,4-dihydro-2H-benzo[h]chromene-5-carboxylic acid 
• 78570-31-7 methyl 1,4-dihydroxy-3-(3-methylbut-2-enyl)-naphthalene-2-carboxylate 
• 55481-88-4 mollugin 
• 870-63-3 prenyl bromide 

Downstream Products

• 55481-88-4 mollugin 

Relevant articles and documents

2-Methoxycarbonyl-3-prenyl-1,4-naphthoquinone, a Metabolite related to the Biosynthesis of Mollugin and Anthraquinones in Galium mollugo L.

The structure of 2-methoxycarbonyl-3-prenyl-1,4-naphthoquinone, isolated from Galium mollugo plants, has been elucidated by spectroscopic methods, synthesis, and derivatisation.

New mollugin analogues and their antioxidant and antibacterial activities

The present invention relates to a new mollugin analogue and medical use thereof and, more specifically to newly synthesized mollugin analogues having both antibacterial and antioxidant activities, which can be effectively used as a medicine for oxidation-related diseases or as an antibacterial agent.

Facile synthesis of mollugin by kinetic control and anti-HCV (Hepatitis C Virus) activity of its analogues

Mollugin has been reported to have various biological activities including antineoplastic, antitumor, antiviral against the hepatitis B virus, anti-aging and antimutagenic activities. An effective and concise synthesis of mollugin in two steps including kinetic control from the cheap starting material 1,4-naphthoquinone has been introduced, and mollugin derivatives thus prepared are screened for their inhibition ability against the hepatitis C virus (HCV) and the dihydrobenzochromene structure might be an additional anti-HCV agent as a new leading compound.